World's Best Scientists 2026 revealed!
Xenofon Baraliakos

Xenofon Baraliakos

D-Index & Metrics

Medicine

D-Index
85
Citations
34986
World Ranking
14421
National Ranking
764

Xenofon Baraliakos publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Xenofon Baraliakos sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 599 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Xenofon Baraliakos D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Xenofon Baraliakos sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Xenofon Baraliakos is affiliated with Ruhr University Bochum in Germany and specializes in the field of Medicine, with a primary focus on Rheumatology. Their scholarly work spans several subfields, including Immunology, Hematology, Orthopedics and Sports Medicine, and Pathology and Forensic Medicine.

The scientist's research covers various topics within rheumatologic and autoimmune disorders. These main topics include:

  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Bone and Joint Diseases
  • Spine and Intervertebral Disc Pathology
  • Fibromyalgia and Chronic Fatigue Syndrome Research

Baraliakos has contributed extensively to academic literature, particularly in the journal Annals of the Rheumatic Diseases, with 182 publications. Additional frequent publication venues include:

  • Lara D. Veeken
  • RMD Open
  • Zeitschrift für Rheumatologie
  • Revue du Rhumatisme

Frequent collaborators of Baraliakos include:

  • Jürgen Braun
  • Uta Kiltz
  • Désirée van der Heijde
  • Denis Poddubnyy
  • David Kiefer

Among notable publications authored or co-authored by Baraliakos are:

  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update" (2020), published in Annals of the Rheumatic Diseases
  • "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" (2022), published in Annals of the Rheumatic Diseases
  • "Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement" (2020), published in Annals of the Rheumatic Diseases
  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update" (2024), published in Annals of the Rheumatic Diseases
  • "Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study" (2021), published in Annals of the Rheumatic Diseases

Best Publications

  • The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

    J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

    Dominique Baeten;Joachim Sieper;Jürgen Braun;Xenofon Baraliakos

  • Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

    M. Rudwaleit;A. G. Jurik;K.-G. A. Hermann;R. Landewé

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

    Martin Rudwaleit;Hildrun Haibel;Xenofon Baraliakos;Joachim Listing

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

    Dominique Baeten;Xenofon Baraliakos;Jürgen Braun;Joachim Sieper

  • EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

    P Mandl;V Navarro-Compán;L Terslev;P Aegerter

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

    Désirée van der Heijde;Robert Landewé;Xenofon Baraliakos;Harry Houben

  • Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

    J. Braun;X. Baraliakos;W. Golder;J. Brandt

  • Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    J. Braun;X. Baraliakos;J. Listing;J. Sieper

  • Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

    Robert G W Lambert;Pauline A C Bakker;Désirée van der Heijde;Ulrich Weber

  • 2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Braun;R. Van Den Berg;X. Baraliakos;H. Boehm

  • Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

    Uta Kiltz;Xenofon Baraliakos;Pantelis Karakostas;Manfred Igelmann

  • Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

    Heiner Appel;Gisela Ruiz-Heiland;Joachim Listing;Jochen Zwerina

  • Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.

    Xenofon Baraliakos;Joachim Listing;Jan Brandt;Angela Zink

  • Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

    X Baraliakos;J Listing;M Rudwaleit;H Haibel

Frequent Co-Authors

Robert Landewé
Robert Landewé University of Amsterdam
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Maxime Dougados
Maxime Dougados Hôpital Cochin
Joachim Listing
Joachim Listing Leibniz Institute for Neurobiology
Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
Mikkel Østergaard
Mikkel Østergaard University of Copenhagen
Filip Van den Bosch
Filip Van den Bosch Ghent University
Laure Gossec
Laure Gossec Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative paths to entering or advancing in medicine? Flexible online programs can help you meet your career goals, especially if you’re balancing education with work or family responsibilities.

For nurses holding an associate degree, exploring rn to bsn programs no clinicals can be an efficient way to earn your Bachelor of Science in Nursing without on-site clinical requirements. This speeds up the process and increases accessibility for working professionals.

Those seeking the highest level of practice nursing may consider the fastest dnp online program to accelerate career advancement. Choosing the shortest dnp program can reduce study time, helping you achieve doctorate-level qualifications on a quicker timeline.

If your goal is to enter nursing quickly, enrolling in a 6 month lpn program online offers a fast-track route into practical nursing, allowing you to start caring for patients sooner.

These flexible, online pathways can help you adapt your education to your lifestyle and move forward in the rewarding field of health care.

Best Scientists Citing Xenofon Baraliakos

Trending Scientists

Recently Published Articles